ANGPTL3 siRNA
Undisclosed metabolic/cardiovascular
Phase 1Active (first in China approval)
Key Facts
Indication
Undisclosed metabolic/cardiovascular
Phase
Phase 1
Status
Active (first in China approval)
Company
About Risen Pharma Tech
Clinical-stage biotech developing small molecule and siRNA drugs for osteoarthritis, oncology, and Alzheimer's disease with international competitiveness.
View full company profile